Pfizer Inc. (PFE)

38.18
NYSE
Prev Close 37.43
Day Low/High 37.65 / 38.28
52 Wk Low/High 27.88 / 40.97
Exchange NYSE
Shares Outstanding 5556.88B
Market Cap 207.99B
P/E Ratio 14.82
Div & Yield N.A. (N.A)

Latest News

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

Pfizer Rated New Hold at Berenberg

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

I see no reason to flee this name, therefore, I am not.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Want to Inject Some Growth Into Your Portfolio? Try This Dividend Stock

Want to Inject Some Growth Into Your Portfolio? Try This Dividend Stock

Pfizer is a quality dividend stock that's now trading at a discount.

If 2021 Becomes the Year of the Party, Party City Could Party On

If 2021 Becomes the Year of the Party, Party City Could Party On

Pent-up demand for parties could give this seller of party goods a shot in the arm if Covid-19 abates, though it isn't a buy-and-hold prospect.

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Electoral risk remains the monster under the bed, and it only grows as our legislators intentionally choose the blame game over honest cooperation.

Jim Cramer: These Stocks Show the Market's Betting on a Vaccine

Jim Cramer: These Stocks Show the Market's Betting on a Vaccine

The prices of hotels and even beaten up retailers say that many believe a vaccine is on the way -- here's how I would get positioned.

How About That Merck and Seattle Genetics Deal?

How About That Merck and Seattle Genetics Deal?

I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Also, several scheduled events this week, election risk, earnings to watch.

Auction Action

The 10-year U.S. note auction was soft. The yield of 0.704% was above the when issued of about 0.695%. The bid to cover of 2.30 was below the 12 month average of 2.47. Also, dealers were left with 27% of the auction vs. the one year average of 25%. ...

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

This writer is rooting for the success of all efforts to halt the spread of the virus as he struggles with the aftereffects of the disease.

Run, Forrest, Run, Rotation Notations, Overreacting to Fauci: Market Recon

Run, Forrest, Run, Rotation Notations, Overreacting to Fauci: Market Recon

Plus, picking up dinged shares among Thursday's wreckage in the tech sector.

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Plus, reading tea leaves in the recent action in Apple and Salesforce.com.

No Ordinary Month, Fear September?, Put/Call Ratio, TikTok Bidding War, Amazon

No Ordinary Month, Fear September?, Put/Call Ratio, TikTok Bidding War, Amazon

How September markets digest August ahead of momentous events will be far more important to uptrend maintenance than how August closed.

Pizza, Splits and Stocks

Apple's weight in the (price-weighted) Dow Jones Industrial Average, effective this morning, will be reduced from 12% to 3% -- based on the company's 4-1 stock split. In response to that split, Amgen , Honeywell , and Salesforce are being added to t...

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Plus, Veeva Systems reports stellar results and ups its guidance.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Amgen Might Be the Right Medicine for the Dow

Amgen Might Be the Right Medicine for the Dow

Let's check the charts as this biotech replaces Pfizer on the DJIA.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

There's a Play to Be Had With Pfizer

There's a Play to Be Had With Pfizer

Getting dropped from the Dow may give PFE the catalyst it needs to make a big move one way or the other.

A Technical Look at the New Dow Jones Industrial Average

A Technical Look at the New Dow Jones Industrial Average

Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.

Bond Prices Will Move Before Normalcy Returns

Bond Prices Will Move Before Normalcy Returns

Here's my 'counterintuitive' bet on lower Treasury prices, and therefore higher rates, right now.